Halaman 4 - Kanker hati Dokter Terbaik - TOP-120 dokter

Associate Professor Dr. Yusuf Acikgoz membawa keahlian onkologi internasional dari Ohio State University ke Rumah Sakit Universitas Lokman Hekim Ankara.

• Spesialisasi dalam Onkologi Medis dengan pelatihan luas
• Berpartisipasi dalam uji klinis Fase III termasuk studi CheckMate-649 dan Fortitude-101
• Menjadi anggota American Society of Clinical Oncology (ASCO) dan Perkumpulan Onkologi Medis Turki
• Tersertifikasi dalam Praktik Klinis yang Baik dan Perlindungan Subjek Manusia

Dr. Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal, merawat pasien di Rumah Sakit Universitas Istinye Liv.

• Associate Professor sejak 2016
• Spesialis Penyakit Dalam di Rumah Sakit Negeri Malatya
• Onkolog di Klinik Onkologi Ankara
• Dokter di Departemen Onkologi di Rumah Sakit Pelatihan dan Penelitian Regional Erzurum

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Spesialis dalam bedah laparoskopi tingkat lanjut dan bedah kanker onkologi di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul.

• Pengalaman lebih dari 20 tahun dalam bedah umum
• Terlatih dalam bedah bariatrik laparoskopi
• Keahlian dalam bedah antirefluks laparoskopi

Professor Madya Nail Paksoy berspesialisasi dalam pengobatan kanker hati di Rumah Sakit Medipol Bahçelievler, dengan pengalaman luas di bidang onkologi medis.

• Tersertifikasi Dewan ESMO dalam Onkologi Medis
• Berpartisipasi dalam berbagai uji klinis internasional untuk pengobatan kanker
• Menerbitkan sejumlah artikel penelitian tentang berbagai topik onkologi
• Menjalani pelatihan fellowship di Institut Onkologi Universitas Istanbul

Profesor Gül Alco berspesialisasi dalam onkologi radiasi untuk kanker hati di Medipol Acibadem District Hospital, dengan pengalaman lebih dari 20 tahun.

• Profesor di Universitas Medipol Istanbul – lembaga medis terkemuka
• Pelatihan ekstensif dalam onkologi radiasi di universitas-universitas ternama di Turki
• Anggota Masyarakat Onkologi Radiasi Turki

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Alemdar berspesialisasi dalam pengobatan kanker hati dengan pelatihan ekstensif dalam onkologi medis di Universitas Akdeniz.

• Tersertifikasi dalam onkologi medis sejak 2018
• Pengalaman lebih dari 15 tahun dalam penyakit dalam dan onkologi
• Bekerja di Medical Park Antalya Hospital Complex

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Babek Tabandeh berspesialisasi dalam bedah kanker hati dan teknik invasif minimal di Rumah Sakit Medical Park Goztepe.

• Pengalaman lebih dari 25 tahun dalam bedah umum
• Anggota Liver Transplantation Society
• Penulis 40+ dokumen medis
• Anggota fakultas di Universitas Bahçeşehir
• Fellow dari American College of Surgeons

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Ozden mengkhususkan diri dalam perawatan kanker hati dengan pelatihan ekstensif dalam onkologi medis dari Universitas Kocaeli.

• Tersertifikasi dalam penyakit dalam dengan pengalaman selama 22 tahun
• Menempuh pendidikan di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul
• Anggota Asosiasi Onkologi Medis Turki

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne menghadirkan pendekatan inovatif dalam pengobatan kanker hati di Klinik Pallas.

• 30+ tahun pengalaman dalam imunologi
• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam

Dr. Volkan Kinas berspesialisasi dalam bedah kanker hati di Rumah Sakit Büyük Anadolu, dengan keahlian dalam bedah onkologi dan pankreas.

• Melakukan operasi saluran empedu dan kanker lambung
• Menjalankan prosedur kanker kolon dan tiroid
• Memiliki pengalaman dalam bedah bariatrik dan metabolik

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.